PBHHIGH SIGNALFINANCIAL10-K

PBH delivered exceptional financial performance with revenue surging 36.8% to $975.8M while simultaneously strengthening its balance sheet through debt reduction and cash generation.

This represents a significant acceleration in business performance, with the company demonstrating strong operational execution across both segments while maintaining disciplined capital allocation. The combination of substantial revenue growth, debt paydown, and doubled cash position suggests PBH has either completed a major acquisition integration successfully or achieved breakthrough organic growth that positions it for sustained outperformance.

Comparing 2025-05-09 vs 2024-05-15View on EDGAR →
FINANCIAL ANALYSIS

PBH's financials reflect exceptional operational performance with revenue jumping 36.8% to $975.8M while the company simultaneously strengthened its balance sheet by reducing total debt 11.9% to $992.4M and more than doubling cash to $97.9M. Interest expense plummeted 65.4% to $1.8M reflecting the debt reduction benefits, while the company returned additional capital to shareholders by doubling share buybacks to $51.5M and growing stockholders' equity 10.9% to $1.8B. This combination of accelerated growth, debt reduction, and strong cash generation signals a company firing on all cylinders with both operational momentum and financial discipline.

FINANCIAL STATEMENT CHANGES
Cash & Equivalents
Balance Sheet
+110.6%
$46.5M→$97.9M

Cash position surged 110.6% — strong cash generation or capital raise providing significant financial cushion.

Share Buybacks
Cash Flow
+106%
$25.0M→$51.5M

Share repurchases increased 106% — management returning capital, signals confidence in intrinsic value.

Interest Expense
P&L
-65.4%
$5.2M→$1.8M

Interest expense declined — debt repayment or refinancing at lower rates improving earnings quality.

Revenue
P&L
+36.8%
$713.5M→$975.8M

Strong top-line growth of 36.8% — accelerating demand or successful expansion into new markets.

Current Assets
Balance Sheet
+19.5%
$375.0M→$448.3M

Current assets grew 19.5% — improving short-term liquidity or inventory/receivables build.

Total Debt
Balance Sheet
-11.9%
$1.1B→$992.4M

Debt reduced 11.9% — deleveraging strengthens balance sheet and reduces financial risk.

Stockholders Equity
Balance Sheet
+10.9%
$1.7B→$1.8B

Equity base grew 10.9% — retained earnings accumulation or equity issuance strengthening the balance sheet.

LANGUAGE CHANGES
NEW — 2025-05-09
PRIOR — 2024-05-15
ADDED
As of May 1, 2025, the registrant had 49,414,707 shares of common stock outstanding.
Our business, business model, competitive strengths and growth strategy face various risks that are described in Part I, Item 1A.
2 The following summarizes the percent of our net revenues by segment during each of the past three fiscal years: March 31, 2025 2024 2023 Segment: North American OTC Healthcare 84.4 % 85.2 % 86.3 % International OTC Healthcare 15.6 14.8 13.7 Total 100.0 % 100.0 % 100.0 % For additional information concerning our business segments, please refer to Part II, Item 7.
Management s Discussion and Analysis of Financial Condition and Results of Operations and Note 18 to the Consolidated Financial Statements included elsewhere in this Annual Report on Form 10-K.
These brands accounted for approximately 83.0%, 83.3% and 81.9% of our total revenues for 2025, 2024, and 2023, respectively.
+7 more — sign up free →
REMOVED
As of May 10, 2024, the registrant had 49,915,366 shares of common stock outstanding.
For more information, see Risk Factors contained in Part I, Item 1A of this Annual Report on Form 10-K.
Our business, business model, competitive strengths and growth strategy face various risks that are described in "Risk Factors" in Part I, Item 1A of this Annual Report on Form 10-K.
2 The following summarizes the percent of our net revenues by segment during each of the past three fiscal years: March 31, 2024 2023 2022 Segment: North American OTC Healthcare 85.2 % 86.3 % 89.1 % International OTC Healthcare 14.8 13.7 10.9 Total 100.0 % 100.0 % 100.0 % For additional information concerning our business segments, please refer to Part II, Item 7, Management s Discussion and Analysis of Financial Condition and Results of Operations and Note 20 to the Consolidated Financial Statements included elsewhere in this Annual Report on Form 10-K.
These brands accounted for approximately 83.3%, 81.9%, and 81.4% of our total revenues for 2024, 2023, and 2022, respectively.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →